Exact Sciences Corp. EXAS

NAS: EXAS | ISIN: US30063P1057 11/07/2025

51,91 USD (-2,64%)

(-2,64%) 11/07/2025

Grafiek Exact Sciences Corp.

Grafiek Exact Sciences Corp.

1 dag1d -2,64%
1 week1w -1,09%
1 maand1m -2,61%
3 maanden3m 17,31%
6 maanden6m -4,23%
1 jaar1j 10,33%
5 jaar5j -44,17%

Exact Sciences Corp. in het nieuws

Toon enkel gratis nieuws

19 maart 2025 · Sera Prognostics Announces Appointment Of Jeff Elliott To Its Board; Ryan Trimble And Marcus Wilson To Step Down · Persbericht

31 juli 2024 · TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology · Persbericht

7 januari 2024 · Exact Sciences Announces Preliminary Fourth Quarter 2023 Results · Persbericht

2 januari 2024 · Exact Sciences to participate in J.P. Morgan Healthcare Conference · Persbericht

7 december 2023 · Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings · Persbericht

1 november 2023 · Exact Sciences Announces Third-Quarter 2023 Results · Persbericht

1 november 2023 · Exact Sciences to participate in November investor conferences · Persbericht

22 oktober 2023 · Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection · Persbericht

21 oktober 2023 · Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress · Persbericht

9 oktober 2023 · Exact Sciences schedules third quarter 2023 earnings call · Persbericht

Profiel Exact Sciences Corp.

Gezondheidstechnologie

Website: www.exactsciences.com

Hoofdzetel: Madison, Wisconsin Verenigde Staten

CEO: Kevin Conroy

Werknemers: 5.120

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe